Robert Paul
CEO @ Nine Square Therapeutics | MD, PhD
- Role
- Chief Executive Officer at Nine Square Therapeutics
- Location
- South San Francisco, CA, US
- LinkedIn followers
- 500 followers
About Robert Paul
I am the Chief Executive Officer at Nine Square Therapeutics, a biotech company that applies cutting-edge computational and experimental methods to discover and develop novel small-molecule therapeutics for life-threatening neurodegenerative diseases. With over 15 years of clinical and research experience in neuroscience and immunology, I have a passion for translating scientific insights into innovative treatments for patients with unmet medical needs. Prior to joining Nine Square Therapeutics, I was the Chief Medical Officer at Alector, a pioneer in immuno-neurology, where I led the clinical development of multiple molecules in frontotemporal dementia, Alzheimer\'s disease, ALS, and oncology. I also oversaw the clinical development of several drug candidates for Alzheimer\'s disease, PSP, ALS, and pain at Genentech, where I held a senior leadership role in the neurology department. In addition, I have extensive business consulting experience in the biopharma industry, having worked at BCG, a top tier firm. I hold an MD, a PhD in neuroscience, and I have published multiple papers in top tier medical and scientific journals.
Experience
Chief Executive Officer
Jan 2022 — Present · South San Francisco, CA, US
Education
Ludwig-Maximilians-Universität München
PhD
Ludwig-Maximilians-Universität München
Habilitation, Neurology
Universität für Weiterbildung Krems
MBA, Biotech/Pharma Managment
2006 — 2010
Ludwig-Maximilians-Universität München
MD, Medical Doctor
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.